---
layout: post
title: 中国生物科技股受美国拟议法案影响大跌
date: 2024-01-26 20:33:03.000000000 +08:00
link: https://cn.wsj.com/amp/articles/%E4%B8%AD%E5%9B%BD%E7%94%9F%E7%89%A9%E7%A7%91%E6%8A%80%E8%82%A1%E5%8F%97%E7%BE%8E%E5%9B%BD%E6%8B%9F%E8%AE%AE%E6%B3%95%E6%A1%88%E5%BD%B1%E5%93%8D%E6%9A%B4%E8%B7%8C-05e95336
categories: wsj
---

<main id="main" role="main">
<div>


</div>
<div itemprop="articleLead" data-sbId="CN-MKT-20240126191937">
    <div>
      <div class="media-object scope-
          header
">
          <figure>
      <div>
        <img
          srcset="https://images.wsj.net/im-917567?width=540&amp;size=1.5005861664712778 540w, https://images.wsj.net/im-917567?width=620&amp;size=1.5005861664712778 620w, https://images.wsj.net/im-917567?width=639&amp;size=1.5005861664712778 639w, https://images.wsj.net/im-917567?width=860&amp;size=1.5005861664712778 860w, https://images.wsj.net/im-917567?width=860&amp;size=1.5005861664712778&amp;pixel_ratio=1.5 1290w, https://images.wsj.net/im-917567?width=860&amp;size=1.5005861664712778&amp;pixel_ratio=2 1720w, https://images.wsj.net/im-917567?width=860&amp;size=1.5005861664712778&amp;pixel_ratio=3 2580w"
          src="https://images.wsj.net/im-917567?width=860&amp;height=573"
          layout="responsive"
          placeholder
          alt="">
        </img>
      </div>
      <figcaption>
        <p>加拉格尔与他人共同提出了一项可能限制一些中国制药公司进入美国市场的法案。</p>
    <p> 图片来源：David Paul Morris/Bloomberg News</p>
  </figcaption>
</figure>

          <!-- eventually when we know what this card will be we can change it and leave this one -->
      </div>
    </div>
</div>
<div data-sbId="CN-MKT-20240126191937">

<div>

  <div>
      <p> </p>
              <p><span itemprop="name">
                <a href="https://www.wsj.com/news/author/dave-sebastian" itemprop="url" rel="author">Dave Sebastian</a>
              </span></p>

  </div>
    <time>
      2024年1月26日19:50 CST 更新
    </time>
</div>

<div subscriptions-actions subscriptions-display="NOT data.noSharing">
  <div>
    <social-share type="system" width="72" height="24"
      data-param-url="https://cn.wsj.com/articles/中国生物科技股受美国拟议法案影响暴跌-05e95336">
    </social-share>
  </div>
</div>


<div subscriptions-section="content">
</div>
<div subscriptions-section="content-not-granted">
</div>



<section subscriptions-section="content">
      <p>无锡药明康德新药开发股份有限公司(WuXi AppTec, 简称:药明康德)及其姊妹公司股价周五大跌，之前美国政界拟议的一项法律可能限制其进入美国市场。</p>
      <p>--药明康德在香港上市的股票下跌16%，创下六个多月以来的最低收盘价。</p>
      <p>--药明生物技术有限公司(Wuxi Biologics, 简称:药明生物)和药明合联生物技术有限公司 (WuXi XDC Cayman Inc., 2268.HK, 简称：药明合联)的股价也录得两位数百分比跌幅。</p>
      <div> <p>--一些在中国大陆上市的生物科技股也出现下跌，其中深圳华大基因股份有限公司(BGI Genomics, 300676.SZ, 简称：华大基因)和深圳华大智造科技股份有限公司(MGI Tech)股价也下跌。</p>
      <div class="media-object scope-
          inline
">
          <figure>
      <div>
        <img
          srcset="https://images.wsj.net/im-917586?width=540&amp;size=1.2403100775193798 540w, https://images.wsj.net/im-917586?width=620&amp;size=1.2403100775193798 620w, https://images.wsj.net/im-917586?width=639&amp;size=1.2403100775193798 639w, https://images.wsj.net/im-917586?width=700&amp;size=1.2403100775193798 700w, https://images.wsj.net/im-917586?width=700&amp;size=1.2403100775193798&amp;pixel_ratio=1.5 1050w, https://images.wsj.net/im-917586?width=700&amp;size=1.2403100775193798&amp;pixel_ratio=2 1400w, https://images.wsj.net/im-917586?width=700&amp;size=1.2403100775193798&amp;pixel_ratio=3 2100w"
          src="https://images.wsj.net/im-917586?width=700&amp;height=564"
          layout="responsive"
          placeholder
          alt="">
        </img>
      </div>
      <figcaption>
      </figcaption>
</figure>

          <!-- eventually when we know what this card will be we can change it and leave this one -->
      </div>
      <p>该法案特别点名药明康德，将阻止向一些中国生物技术公司提供联邦合同、赠与和贷款。药明康德帮助制药商开展研究、开发和生产新产品。</p>
      <p>该法案由共和党人加拉格尔(Mike Gallagher)和民主党人克里希纳穆尔提(Raja Krishnamoorthi)于周四在众议院提出，他们是众议院中共问题特设委员会(Select Committee on the Chinese Communist Party)的两位资历最深的成员。在此之前，参议院也提出了类似提案。</p>
      <p>药明康德未回应置评请求。</p>
      </div>
</section>

</div>
      </main>
